![Jeff Saunders](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeff Saunders
Geen lopende functies
Profiel
Jeff Saunders worked as Vice President-Chemistry at Agios Pharmaceuticals, Inc. and as Vice President-Small Molecule Discovery at Ember Therapeutics, Inc. He received an undergraduate degree from Hope College and a doctorate degree from the University of South Carolina.
Eerdere bekende functies van Jeff Saunders
Bedrijven | Functie | Einde |
---|---|---|
AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ember Therapeutics, Inc. /Old/
![]() Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Opleiding van Jeff Saunders
Hope College | Undergraduate Degree |
University of South Carolina | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AGIOS PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Ember Therapeutics, Inc. /Old/
![]() Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Health Technology |